The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March

Rhea-AI Summary

The Oncology Institute (NASDAQ: TOI) announced executive participation in three investor conferences in March 2026. Presentations include Jefferies Healthcare Services Innovation & Technology Summit and Leerink Global Healthcare Conference on March 9 in Miami, and Oppenheimer MedTech & Services Conference (virtual) on March 16.

Presenters include Dr. Daniel Virnich, CEO, and Rob Carter, CFO; webcasts and replays will be available via the company Investor Relations site.

Key Figures

Jefferies presentation date: March 9, 2026 Jefferies time window: 11:30 a.m.–12:00 p.m. ET Leerink presentation date: March 9, 2026 +5 more

8 metrics

Jefferies presentation date March 9, 2026 Jefferies Healthcare Services Innovation & Technology Summit

Jefferies time window 11:30 a.m.–12:00 p.m. ET Conference presentation slot

Leerink presentation date March 9, 2026 Leerink Global Healthcare Conference

Leerink time window 3:00 p.m.–3:30 p.m. ET Conference presentation slot

Oppenheimer presentation date March 16, 2026 Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Oppenheimer time window 10:00 a.m.–10:30 a.m. ET Virtual conference presentation slot

Oppenheimer edition 36th Annual Oppenheimer Healthcare MedTech & Services Conference

Pre-news share price $2.58 Price before February 25, 2026 conference announcement

Market Reality Check

Price: $2.58 Vol: Volume 1,120,933 vs 20-da...

low vol

$2.58 Last Close

Volume Volume 1,120,933 vs 20-day average 1,827,938, indicating relatively lighter trading activity before this announcement. low

Technical Shares at $2.58, trading below the 200-day moving average of $3.33 ahead of the conference updates.

Peers on Argus

TOI was up 1.18% pre-news while peers were mixed: JYNT -0.87%, DCGO +0.69%, BTMD...

TOI was up 1.18% pre-news while peers were mixed: JYNT -0.87%, DCGO +0.69%, BTMD +0.49%, CCRN +1.51%, CYH +4.49%. No coordinated sector move is indicated.

Historical Context

5 past events · Latest: Feb 23 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 23	Board appointment	Positive	-0.4%	Experienced healthcare executive appointed to TOI’s Board of Directors.
Jan 12	Guidance & outlook	Positive	-7.9%	Reaffirmed 2025 guidance and provided preliminary 2026 revenue and EBITDA outlook.
Jan 9	Leadership promotions	Positive	-3.0%	Promotions of CIO and CPO to support technology and people strategy.
Jan 2	Board addition	Positive	+6.8%	Addition of experienced CFO from another healthcare company to the Board.
Dec 1	Board resignation	Negative	-6.4%	Resignation of Board member and initiation of search for new directors.

Pattern Detected

Recent positive strategic and leadership updates have often seen mixed to negative next-day price reactions, with only some governance changes aligning with price gains.

Recent Company History

Over the past few months, TOI has focused on governance and strategic positioning. New board members were added on Jan 2, 2026 and Feb 23, 2026, and leadership promotions were announced on Jan 9, 2026. The company also reaffirmed 2025 guidance and outlined a 2026 outlook on Jan 12, 2026. Price reactions have been mixed, with several positive-sounding updates followed by negative moves and only some board additions drawing a positive response.

Market Pulse Summary

This announcement highlights TOI’s plan to increase investor engagement through multiple March confe...

Analysis

This announcement highlights TOI’s plan to increase investor engagement through multiple March conferences, featuring both the CEO and CFO. Against a backdrop of recent board changes, leadership promotions, and previously outlined revenue and EBITDA outlooks, these appearances provide additional communication touchpoints. Investors may watch for any updates to strategy, growth expectations, or execution milestones relative to prior guidance and governance moves announced since December 2025.

AI-generated analysis. Not financial advice.

CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership team will participate in several investor conferences in March.

Details for the conferences are as follows:

• Jefferies Healthcare Services Innovation & Technology Summit
  Presentation: Monday, March 9, 2026, from 11:30 a.m. to 12:00 p.m. ET
  Location: Miami, FL
  Presenter: Dr. Daniel Virnich, Chief Executive Officer
• Leerink Global Healthcare Conference
  Presentation: Monday, March 9, 2026, from 3:00 p.m. to 3:30 p.m. ET
  Location: Miami, FL
  Presenter: Rob Carter, Chief Financial Officer
• Oppenheimer 36th Annual Healthcare MedTech & Services Conference
  Presentation: Monday, March 16, 2026, from 10:00 a.m. to 10:30 a.m. ET
  Location: Virtual
  Presenters: Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer
  

Where available, live webcasts and replays of the presentations will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.

About The Oncology Institute (www.theoncologyinstitute.com):

Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com

Investors
ICR Healthcare
TOI@icrhealthcare.com

FAQ

When will The Oncology Institute (TOI) present at the Jefferies Healthcare Services Innovation & Technology Summit?

The presentation is scheduled for Monday, March 9, 2026, from 11:30 a.m. to 12:00 p.m. ET. According to the company, Dr. Daniel Virnich, CEO, will present in Miami, and a live webcast or replay will be available on the company's Investor Relations site.

What time is The Oncology Institute (TOI) presenting at the Leerink Global Healthcare Conference on March 9, 2026?

TOI will present on Monday, March 9, 2026, from 3:00 p.m. to 3:30 p.m. ET. According to the company, Rob Carter, CFO, will be the presenter in Miami and the presentation will be accessible via the Investor Relations webcasts when available.

Who will represent The Oncology Institute (TOI) at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference?

Dr. Daniel Virnich, CEO, and Rob Carter, CFO, will present at the Oppenheimer conference on Monday, March 16, 2026, from 10:00 a.m. to 10:30 a.m. ET. According to the company, that session will be held virtually with webcast access via Investor Relations.

Will The Oncology Institute (TOI) provide webcasts or replays of the March 2026 investor presentations?

Yes. Webcasts and replays will be available where provided, accessible through the company's Investor Relations website. According to the company, presentations that offer live streams will later have replays posted at https://investors.theoncologyinstitute.com/.

Which executives from The Oncology Institute (TOI) will present at investor conferences in March 2026?

The announced presenters are Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer. According to the company, Virnich will present at Jefferies and Oppenheimer, while Carter will present at Leerink and co-present at Oppenheimer.

Where and when is The Oncology Institute (TOI) hosting its March 9, 2026 investor presentations?

Both March 9, 2026 presentations will be held in Miami, Florida: Jefferies at 11:30 a.m.–12:00 p.m. ET and Leerink at 3:00 p.m.–3:30 p.m. ET. According to the company, each session will list webcast details on its Investor Relations page.